Our Pricing

Understanding Cold Sore Transmission Through Each Development Stage

Understanding how do cold sores spread stages is essential for preventing transmission and managing outbreaks effectively. Cold sores, caused by herpes simplex virus type 1 (HSV-1), progress through five distinct stages, with contagiousness varying significantly at each phase. At Cured Pharmacy, our UK-registered clinical team helps patients recognise these stages early and access appropriate antiviral treatments like aciclovir to reduce outbreak duration and transmission risk.

How Cold Sores Are Transmitted Between People

Cold sores spread primarily through direct contact with active lesions or infected saliva. HSV-1 transmission occurs when the virus particles from a cold sore come into contact with broken skin or mucous membranes in another person [1]. This can happen through kissing, sharing utensils, towels, or lip products, or touching an active cold sore and then touching another area of your body or someone else.

The virus is most contagious when visible blisters are present, but transmission can occur even during asymptomatic periods through viral shedding [2]. Studies show that HSV-1 can be detected in saliva of infected individuals approximately 9-18% of days when no symptoms are present, though viral load is significantly lower than during active outbreaks [2].

Once HSV-1 enters the body, it travels along nerve pathways to establish latent infection in nerve ganglia, where it remains dormant until triggered by factors such as stress, illness, sun exposure, or immune suppression [1]. Approximately 67% of the global population under age 50 carries HSV-1, though not all infected individuals experience recurrent cold sore outbreaks [3].

Stage 1: Prodrome Phase (Day 0-1)

The prodrome phase marks the earliest warning signs before a visible cold sore appears. During this 6-24 hour window, patients typically experience tingling, itching, burning, or numbness around the lip area where the outbreak will develop [4]. Some individuals also report localised pain, tenderness, or a sensation of tightness in the affected area.

This stage represents the optimal treatment window. Antiviral medications like aciclovir are most effective when initiated during the prodrome phase, as they can significantly reduce blister formation and shorten outbreak duration [4]. Our UK prescribers recommend starting treatment at the very first sign of tingling to maximise therapeutic benefit.

Viral replication is already occurring beneath the skin surface during this phase, making transmission possible even before visible symptoms appear. Avoiding close contact and maintaining strict hygiene practices becomes important as soon as prodromal symptoms begin.

Recognising Early Warning Signs

Learning to identify your personal prodrome symptoms allows for immediate intervention. Keep aciclovir cream readily available so you can apply it within the critical first 24 hours. Patients who consistently treat during the prodrome phase report fewer severe outbreaks and faster healing times compared to those who wait for visible blisters to form [4].

Stage 2: Blister Formation (Day 1-2)

Small, fluid-filled blisters emerge during this stage, typically appearing as clusters on or around the lips. These vesicles contain high concentrations of viral particles, making this the most contagious phase of cold sore development [1]. The blisters may be painful and are often accompanied by redness and swelling in the surrounding tissue.

The fluid inside these blisters is teeming with infectious HSV-1 particles. Any contact with this fluid—whether through kissing, sharing items, or touching the sore and then touching another person—can readily transmit the virus. This stage typically lasts 1-2 days before progressing to the weeping phase.

Strict hygiene measures are essential during blister formation. Wash hands thoroughly after any contact with the affected area, avoid touching the blisters, and refrain from sharing personal items. Topical aciclovir cream from £4.49 can help reduce viral replication and may shorten this highly contagious phase when applied as directed.

Stage 3: Weeping and Ulceration (Day 2-4)

The blisters rupture during this stage, releasing viral fluid and forming shallow, painful ulcers. This weeping phase represents the peak of contagiousness, as the open sores actively shed large quantities of infectious virus particles [1]. The exposed ulcers are typically red, raw, and extremely tender to touch.

Patients often describe this as the most uncomfortable stage due to pain, oozing, and difficulty with eating or speaking if the sore is positioned near the mouth opening. The ulcerated area may appear moist and inflamed, and secondary bacterial infection can occasionally occur if proper hygiene is not maintained.

Transmission risk remains extremely high throughout this phase. Avoid all direct contact with others, do not share eating utensils or drinking vessels, and be particularly cautious around infants and immunocompromised individuals who are at higher risk for severe HSV-1 complications. Continue antiviral treatment as prescribed to support healing and reduce viral load.

Managing Pain and Preventing Spread

Over-the-counter pain relief may help manage discomfort during the weeping stage. Keep the area clean and dry, avoid picking at the sore, and apply aciclovir cream as directed. Using a separate towel and avoiding intimate contact until complete healing occurs helps protect household members and close contacts from transmission.

Stage 4: Scabbing and Crusting (Day 4-7)

As the ulcer begins to heal, a scab forms over the affected area. This crusty covering protects the healing tissue underneath and marks a transition toward reduced contagiousness. However, the scab may crack or bleed if facial movements stretch the area, potentially exposing infectious material [4].

The scabbing phase typically lasts 2-3 days and can be uncomfortable as the dried crust feels tight and may itch. Patients should resist the urge to pick at or remove the scab, as premature removal can delay healing, increase scarring risk, and potentially spread virus particles from any remaining active lesion beneath.

While contagiousness decreases during this stage compared to the weeping phase, HSV-1 can still be transmitted through contact with the scab or any fluid that seeps from cracks in the crust. Maintain hygiene precautions and continue avoiding close contact until the scab falls off naturally and complete re-epithelialisation occurs.

Stage 5: Healing and Resolution (Day 7-10)

The scab eventually falls off, revealing new pink skin underneath. This final healing stage sees the affected area return to normal appearance over several days, though some temporary discolouration or sensitivity may persist [4]. Complete healing typically occurs within 7-10 days from initial symptom onset, though this timeline varies based on individual immune response and whether antiviral treatment was used.

Once the skin has fully healed with no remaining scab, crust, or visible lesion, transmission risk drops significantly. However, viral shedding can still occur intermittently even after complete healing, which is why HSV-1 remains a lifelong infection that requires ongoing management [2].

Patients who experience frequent recurrent outbreaks—typically defined as six or more episodes per year—may benefit from suppressive antiviral therapy. Our UK prescribers can assess whether daily aciclovir treatment is appropriate for reducing outbreak frequency and duration. All prescription treatments require clinical assessment by a UK-registered prescriber to ensure safety and suitability.

Preventing Future Outbreaks

Identifying and avoiding personal triggers helps reduce recurrence. Common triggers include stress, fatigue, sun exposure, hormonal changes, and immune suppression from illness. Using lip balm with SPF protection, managing stress levels, and maintaining good overall health can help minimise future cold sore episodes. Keep aciclovir cream readily available to treat new outbreaks at the earliest prodromal signs.

Scientific References

1. Arduino, P. G., & Porter, S. R. (2008). Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. Journal of Oral Pathology & Medicine, 37(2), 107-121. https://doi.org/10.1111/j.1600-0714.2007.00586.x
2. Wald, A., & Corey, L. (2007). Persistence in the population: epidemiology, transmission. In Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge University Press. https://www.ncbi.nlm.nih.gov/books/NBK47447/
3. World Health Organization. (2022). Herpes simplex virus. WHO Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus
4. Spruance, S. L., et al. (1997). Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial. Journal of Infectious Diseases, 175(5), 1371-1377. https://doi.org/10.1086/516465

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.